Velneperit clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How each study uses velneperit is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses velneperit is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie DietCompletedPhase 2ShionogiNCT00747929Written as S-2367 800 mg
- Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie DietCompletedPhase 2ShionogiNCT00748605Written as S-2367 1600 mg q.d. 54 Weeks
- Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese SubjectsCompletedPhase 2ShionogiNCT01126970Written as Velneperit 400 mg
- Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese SubjectsCompletedPhase 2ShionogiNCT00788528Written as S-2367 (velneperit)
Codes
What other systems call velneperit · ClinicalTrials.gg INT014179
- UNII (FDA) 09BQ2KJ22JVELNEPERITConfirmed FDA, Wikidata
- Wikidata Q27236469velneperitConfirmed FDA, Wikidata
- NCI Thesaurus C152850VelneperitOne source FDA
- DrugBank DB12889One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 09BQ2KJ22J | VELNEPERIT | Confirmed FDA, Wikidata |
| Wikidata | Q27236469 | velneperit | Confirmed FDA, Wikidata |
| NCI Thesaurus | C152850 | Velneperit | One source FDA |
| DrugBank | DB12889 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.